These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28079159)

  • 1. SOCS1 favors the epithelial-mesenchymal transition in melanoma, promotes tumor progression and prevents antitumor immunity by PD-L1 expression.
    Berzaghi R; Maia VS; Pereira FV; Melo FM; Guedes MS; Origassa CS; Scutti JB; Matsuo AL; Câmara NO; Rodrigues EG; Travassos LR
    Sci Rep; 2017 Jan; 7():40585. PubMed ID: 28079159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
    Song S; Wang Y; Wang J; Lian W; Liu S; Zhang Z; Liu F; Wei L
    Eur J Cancer; 2012 Sep; 48(14):2252-9. PubMed ID: 22230748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibiting effect of IL-10 in tumor microenvironment on anti-tumor activity of SOCS1-silenced DC vaccine].
    Wang Z; You H; Song S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Apr; 29(4):379-83. PubMed ID: 23643168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of SOCS1 silencing on proliferation and apoptosis of melanoma cells: An in vivo and in vitro study.
    Yu SJ; Long ZW
    Tumour Biol; 2017 May; 39(5):1010428317694315. PubMed ID: 28466787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
    Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
    J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
    Oba T; Makino K; Kajihara R; Yokoi T; Araki R; Abe M; Minderman H; Chang AE; Odunsi K; Ito F
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34049930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation gene expression of miR200c and ZEB1 positively enhances effect of tumor vaccine B16F10/GPI-IL-21 on inhibition of melanoma growth and metastasis.
    Wang X; He X; Zhao F; Wang J; Zhang H; Shi F; Zhang Y; Cai K; Dou J
    J Transl Med; 2014 Mar; 12():68. PubMed ID: 24625224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of suppressors of cytokine signaling 1 inhibition of epithelial-mesenchymal transition signaling through ROS regulation in colon cancer cells: suppression of Src leading to thioredoxin up-regulation.
    Jung SH; Kim SM; Lee CE
    Oncotarget; 2016 Sep; 7(38):62559-62571. PubMed ID: 27613835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1.
    Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S
    World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 promotes resistance of melanoma with PD-L1 high expression to T-cell-mediated cytotoxicity that can be reversed by SAHA.
    Wu R; Wang C; Li Z; Xiao J; Li C; Wang X; Kong P; Cao J; Huang F; Li Z; Huang Y; Chen Y; Li X; Yang D; Zhang H; Mai J; Feng G; Deng R; Zhu X
    J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33158915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-29a suppresses the invasion and migration of osteosarcoma cells by regulating the SOCS1/NF-κB signalling pathway through negatively targeting DNMT3B.
    Gong HL; Tao Y; Mao XZ; Song DY; You D; Ni JD
    Int J Mol Med; 2019 Oct; 44(4):1219-1232. PubMed ID: 31364725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
    Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
    Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer.
    Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W
    Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
    Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
    Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced anti-tumor activity of interferon-alpha in SOCS1-deficient mice is mediated by CD4⁺ and CD8⁺ T cells.
    Guenterberg KD; Lesinski GB; Mundy-Bosse BL; Karpa VI; Jaime-Ramirez AC; Wei L; Carson WE
    Cancer Immunol Immunother; 2011 Sep; 60(9):1281-8. PubMed ID: 21604070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SPTBN1 inhibits inflammatory responses and hepatocarcinogenesis via the stabilization of SOCS1 and downregulation of p65 in hepatocellular carcinoma.
    Lin L; Chen S; Wang H; Gao B; Kallakury B; Bhuvaneshwar K; Cahn K; Gusev Y; Wang X; Wu Y; Marshall JL; Zhi X; He AR
    Theranostics; 2021; 11(9):4232-4250. PubMed ID: 33754058
    [No Abstract]   [Full Text] [Related]  

  • 17. REX1 promotes EMT-induced cell metastasis by activating the JAK2/STAT3-signaling pathway by targeting SOCS1 in cervical cancer.
    Zeng YT; Liu XF; Yang WT; Zheng PS
    Oncogene; 2019 Oct; 38(43):6940-6957. PubMed ID: 31409905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Immunomodulatory Gallotanin-Rich Fraction From
    Lasso P; Gomez-Cadena A; Urueña C; Donda A; Martinez-Usatorre A; Romero P; Barreto A; Fiorentino S
    Front Immunol; 2020; 11():584959. PubMed ID: 33312174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCR5 Blockade Suppresses Melanoma Development Through Inhibition of IL-6-Stat3 Pathway via Upregulation of SOCS3.
    Tang Q; Jiang J; Liu J
    Inflammation; 2015 Dec; 38(6):2049-56. PubMed ID: 26047948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of SOCS1 in macrophages suppresses tumor development by enhancing antitumor inflammation.
    Hashimoto M; Ayada T; Kinjyo I; Hiwatashi K; Yoshida H; Okada Y; Kobayashi T; Yoshimura A
    Cancer Sci; 2009 Apr; 100(4):730-6. PubMed ID: 19469017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.